Grant: CIHR Fellowship
McMaster University
$135,000.00
Discovery and molecular mechanism of key virulence markers found in Crohn's Disease-associated adherent invasive Escherichia coli for the development of novel therapeutics
EF 2014-15
Résumé
Crohn's disease and ulcerative colitis are two forms of inflammatory bowel disease (IBD) that have become a major health problem in the western world. Approximately 1 in every 150 Canadians and 1 in every 230 Americans have some form of IBD. Economically, it costs at least 3 billon dollars a year to combat the disease and has now become a greater burden to the healthcare system then treating hospital-acquired infections. Crohn's disease can affect the entire digestive tract and depends on multiple factors including but not limited to genetic predisposition, environmental factors, and an altered gut microbiome. Crohn's disease is a chronic disease that can elicit minor to severe symptoms and does not have a current treatment regiment. Recently, it has been discovered that a type of Escherichia coli, called AIEC (adherent-invasive E. coli), is prevalent within Crohn's disease patients. Individuals who have suffered from acute foodborne illness or have been on antibiotic treatment appear to be more susceptible to Crohn's disease and we are interested in whether there are interactions between these known risk factors and AIEC infections. This proposal focuses on identifying and characterizing the genetic elements responsible for the colonization of AIEC in susceptible hosts. Clear understanding of the link between these genes and chronic gut inflammation will lead to better diagnostic tools and treatment avenues for Crohn's disease.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318364
Name
Little Dustin J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Discovery and molecular mechanism of key virulence markers found in Crohn's Disease-associated adherent invasive Escherichia coli for the development of novel therapeutics
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adherent-Invasive E. Coli; Antibiotic Exposure; Biofilm Infection; Chemokines; Crohn'S Disease; Genetic Susceptibility; Gut Microflora; Inflammatory Bowel Disease; Mouse Model; Signature Tagged Mutagenesis
Abstract
Crohn's disease and ulcerative colitis are two forms of inflammatory bowel disease (IBD) that have become a major health problem in the western world. Approximately 1 in every 150 Canadians and 1 in every 230 Americans have some form of IBD. Economically, it costs at least 3 billon dollars a year to combat the disease and has now become a greater burden to the healthcare system then treating hospital-acquired infections. Crohn's disease can affect the entire digestive tract and depends on multiple factors including but not limited to genetic predisposition, environmental factors, and an altered gut microbiome. Crohn's disease is a chronic disease that can elicit minor to severe symptoms and does not have a current treatment regiment. Recently, it has been discovered that a type of Escherichia coli, called AIEC (adherent-invasive E. coli), is prevalent within Crohn's disease patients. Individuals who have suffered from acute foodborne illness or have been on antibiotic treatment appear to be more susceptible to Crohn's disease and we are interested in whether there are interactions between these known risk factors and AIEC infections. This proposal focuses on identifying and characterizing the genetic elements responsible for the colonization of AIEC in susceptible hosts. Clear understanding of the link between these genes and chronic gut inflammation will lead to better diagnostic tools and treatment avenues for Crohn's disease.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Little, Dustin J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~